对癌症的新见解:MDM2与素酶PADI4结合
Salomé Araujo-Abad1,2, Bruno Rizzuti3,4, Adrián Villamarin-Ortiz5
1IDIBE, Universidad Miguel Hernández, Elche, Spain.
概括
丁氨酸减小酶4 (PADI4) 酶与MDM2相互作用,MDM2是一种调节瘤抑制剂p53.3的蛋白质. 在癌细胞中这种PADI4-MDM2相互作用表明了癌症治疗的潜在新疗法策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 基氨酸脱酶4 (PADI4) 催化氨酸转化为氨酸.
- MDM2 是一种E3 泛素酶,对p53瘤抑制剂降解至关重要.
- PADI4和MDM2都参与了p53的信号通路.
研究的目的:
- 调查PADI4和MDM2.2之间的潜在直接相互作用.
- 探索这种相互作用在癌症中的相关性.
- 阐明结合部位和相互作用机制.
主要方法:
- 在癌症细胞系中进行共免疫沉降测定.
- 使用GSK484.4.进行酶抑制研究.
- 在基分子对接和模拟.
- 在体外结合测定与分离的蛋白质域.
主要成果:
- 发现PADI4和MDM2在癌细胞的核和细胞分裂区中都存在关联.
- PADI4抑制剂GSK484降低了结合,表明MDM2可能会准PADI4的活性部位.
- 在和体外研究证实了MDM2 (N-MDM2) 的N端区域与PADI4.4之间的相互作用.
- 在N-MDM2上的特定残留物 (Thr26,Val28,Phe91,Lys98) 被确定为关键的相互作用点.
结论:
- 在癌细胞中证明了PADI4和MDM2之间的直接相互作用.
- 这种相互作用涉及MDM2与PADI4.4的活性部位的结合.
- 这种相互作用可能导致MDM2素化,通过新抗原生成为癌症治疗提供潜在的治疗途径.
关键词:
MDM2DM2 在线播放这是NMR的NMR.在PADI4上,您可以使用PADI4.素化是指素化.异热定位热量计 异热定位热量计分子对接的分子对接.蛋白质结合检测试验 蛋白质结合检测试验蛋白质与蛋白质的相互作用更多相关视频
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Negative Regulator Molecules
35.5K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
Covalently Linked Protein Regulators
6.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.9K


